Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

APOE genotype makes a small contribution to warfarin dose requirements.

Sconce EA, Daly AK, Khan TI, Wynne HA, Kamali F.

Pharmacogenet Genomics. 2006 Aug;16(8):609-11.

PMID:
16847429
2.

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin.

Kamali F, Khan TI, King BP, Frearson R, Kesteven P, Wood P, Daly AK, Wynne H.

Clin Pharmacol Ther. 2004 Mar;75(3):204-12.

PMID:
15001972
3.

Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin.

Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P, Kesteven P, Kamali F.

Br J Haematol. 2004 Feb;124(3):348-54.

PMID:
14717783
4.

Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants.

Visser LE, Trienekens PH, De Smet PA, Vulto AG, Hofman A, van Duijn CM, Stricker BH.

Pharmacogenet Genomics. 2005 Feb;15(2):69-74.

PMID:
15861030
5.

Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.

Cavallari LH, Butler C, Langaee TY, Wardak N, Patel SR, Viana MA, Shapiro NL, Nutescu EA.

Pharmacotherapy. 2011 Aug;31(8):785-92. doi: 10.1592/phco.31.8.785.

PMID:
21923605
6.

CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.

Peyvandi F, Spreafico M, Siboni SM, Moia M, Mannucci PM.

Clin Pharmacol Ther. 2004 Mar;75(3):198-203.

PMID:
15001971
7.

Association between apolipoprotein E gene polymorphism and the dose for warfarin maintenance.

Huang S, Chen B, Xiang D, Huang L, An B, Li G.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Mar;36(3):212-6. doi: 10.3969/j.issn.1672-7347.2011.03.004.

9.

Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans.

Kimmel SE, Christie J, Kealey C, Chen Z, Price M, Thorn CF, Brensinger CM, Newcomb CW, Whitehead AS.

Pharmacogenomics J. 2008 Feb;8(1):53-60. Epub 2007 Feb 27.

PMID:
17325732
10.

The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.

Kamali F, Edwards C, Butler TJ, Wynne HA.

Thromb Haemost. 2000 Jul;84(1):39-42.

PMID:
10928467
11.

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.

PMID:
17689519
12.

Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population.

Liu R, Zhang K, Gong ZZ, Shi XM, Zhang Q, Pan XD, Dong R.

Lipids Health Dis. 2016 Feb 24;15:34. doi: 10.1186/s12944-016-0205-8.

13.

Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients.

Lal S, Sandanaraj E, Jada SR, Kong MC, Lee LH, Goh BC, Lee SC, Chowbay B.

Br J Clin Pharmacol. 2008 Feb;65(2):260-4. Epub 2007 Nov 8.

14.
15.

Influence of APOE Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement: A Systematic Review and Meta-Analysis.

Yu WY, Sun X, Wadelius M, Huang L, Peng C, Ma WL, Yang GP.

Cardiovasc Ther. 2016 Oct;34(5):297-307. doi: 10.1111/1755-5922.12186. Review.

PMID:
27062534
16.

Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study.

de Oliveira Almeida VC, Ribeiro DD, Gomes KB, Godard AL.

Mol Diagn Ther. 2014 Dec;18(6):675-83. doi: 10.1007/s40291-014-0121-4.

PMID:
25312789
17.

Apolipoprotein E gene and retinal microvascular signs in older people: the Cardiovascular Health Study.

Sun C, Tikellis G, Liew G, Klein R, Larsen EK, Wong TY.

Mol Vis. 2007 Nov 12;13:2105-11.

PMID:
18079687
18.

Warfarin dose related to apolipoprotein E (APOE) genotype.

Kohnke H, Sörlin K, Granath G, Wadelius M.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):381-8. Epub 2005 Jun 11.

PMID:
15952022
19.

Plasma levels of apolipoprotein E and cognitive function in old age.

Mooijaart SP, van Vliet P, van Heemst D, Rensen PC, Berbée JF, Jolles J, de Craen AJ, Westendorp RG.

Ann N Y Acad Sci. 2007 Apr;1100:148-61.

PMID:
17460173
20.

Factors determining the maintenance dose of warfarin in Chinese patients.

Yu HC, Chan TY, Critchley JA, Woo KS.

QJM. 1996 Feb;89(2):127-35.

PMID:
8729554

Supplemental Content

Support Center